10-K Filing

BIO-PATH HOLDINGS, INC. CIK: 1133818 FY 2014

Filing Information

Form Type	10-K
Accession Number	`0001144204-15-016335`
Period End Date	20141231
Filing Date	20150316
Fiscal Year	2014
Fiscal Period	FY
XBRL Instance	bpth-20141231.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 73 Income Statement 99 Cash Flow Statement 80 Stockholders Equity 29

Balance Sheet 73 line items

Line Item	Tag	Value	Unit	Period
Preferred Stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred Stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred Stock, shares authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Preferred Stock, shares authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Cash	`Cash`	$13.86M	USD	Point-in-time
Cash	`Cash`	$3.55M	USD	Point-in-time
Cash	`Cash`	$952.25K	USD	Point-in-time
Preferred Stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Cash	`Cash`	$534.05K	USD	Point-in-time
Preferred Stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Prepaid drug product for testing	`OtherInventory`	$51.36K	USD	Point-in-time
Prepaid drug product for testing	`OtherInventory`	$154.67K	USD	Point-in-time
Preferred Stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Preferred Stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Common Stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$64.12K	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$100.49K	USD	Point-in-time
Common Stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common Stock, shares authorized	`CommonStockSharesAuthorized`	200.00M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$14.11M	USD	Point-in-time
Common Stock, shares authorized	`CommonStockSharesAuthorized`	200.00M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$3.67M	USD	Point-in-time
Common Stock, shares issued	`CommonStockSharesIssued`	84.24M	shares	Point-in-time
Common Stock, shares issued	`CommonStockSharesIssued`	89.76M	shares	Point-in-time
Common Stock, shares issued	`CommonStockSharesIssued`	489,501.00	shares	Point-in-time
Common Stock, shares issued	`CommonStockSharesIssued`	62.22M	shares	Point-in-time
Common Stock, shares outstanding	`CommonStockSharesOutstanding`	84.24M	shares	Point-in-time
Common Stock, shares outstanding	`CommonStockSharesOutstanding`	62.22M	shares	Point-in-time
Furniture, fixtures & equipment	`PropertyPlantAndEquipmentGross`	-	USD	Point-in-time
Furniture, fixtures & equipment	`PropertyPlantAndEquipmentGross`	$123.41K	USD	Point-in-time
Common Stock, shares outstanding	`CommonStockSharesOutstanding`	89.76M	shares	Point-in-time
Less Accumulated Depreciation	`AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment`	$10.28K	USD	Point-in-time
Less Accumulated Depreciation	`AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment`	-	USD	Point-in-time
Property, Plant and Equipment, Net	`PropertyPlantAndEquipmentNet`	-	USD	Point-in-time
Property, Plant and Equipment, Net	`PropertyPlantAndEquipmentNet`	$113.13K	USD	Point-in-time
Technology licenses - related party	`FiniteLivedLicenseAgreementsGross`	$2.50M	USD	Point-in-time
Technology licenses - related party	`FiniteLivedLicenseAgreementsGross`	$2.50M	USD	Point-in-time
Less Accumulated Amortization	`FiniteLivedIntangibleAssetsAccumulatedAmortization`	$1.09M	USD	Point-in-time
Less Accumulated Amortization	`FiniteLivedIntangibleAssetsAccumulatedAmortization`	$1.25M	USD	Point-in-time
Intangible Assets, Net (Excluding Goodwill), Total	`IntangibleAssetsNetExcludingGoodwill`	$1.25M	USD	Point-in-time
Intangible Assets, Net (Excluding Goodwill), Total	`IntangibleAssetsNetExcludingGoodwill`	$1.41M	USD	Point-in-time
TOTAL ASSETS	`Assets`	$15.48M	USD	Point-in-time
TOTAL ASSETS	`Assets`	$5.08M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$41.03K	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$76.11K	USD	Point-in-time
Accounts payable - related party	`AccountsPayableRelatedPartiesCurrentAndNoncurrent`	-	USD	Point-in-time
Accounts payable - related party	`AccountsPayableRelatedPartiesCurrentAndNoncurrent`	$100.45K	USD	Point-in-time
Accrued expense	`AccruedLiabilitiesCurrent`	$253.44K	USD	Point-in-time
Accrued expense	`AccruedLiabilitiesCurrent`	$66.74K	USD	Point-in-time
Accrued expense - related party	`AccruedLiabilitiesRelatedPartiesCurrent`	$52.05K	USD	Point-in-time
Accrued expense - related party	`AccruedLiabilitiesRelatedPartiesCurrent`	$67.05K	USD	Point-in-time
Accrued license payments - related party	`DueToRelatedPartiesCurrent`	$100.00K	USD	Point-in-time
Accrued license payments - related party	`DueToRelatedPartiesCurrent`	$100.00K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$294.90K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$561.97K	USD	Point-in-time
Long term debt	`LongTermDebtNoncurrent`	-	USD	Point-in-time
Long term debt	`LongTermDebtNoncurrent`	-	USD	Point-in-time
TOTAL LIABILITIES	`Liabilities`	$294.90K	USD	Point-in-time
TOTAL LIABILITIES	`Liabilities`	$561.97K	USD	Point-in-time
Preferred Stock, $.001 par value 10,000,000 shares authorized, no shares issued and outstanding	`PreferredStockValue`	-	USD	Point-in-time
Preferred Stock, $.001 par value 10,000,000 shares authorized, no shares issued and outstanding	`PreferredStockValue`	-	USD	Point-in-time
Common Stock, $.001 par value, 200,000,000 shares authorized 89,762,872 and 84,237,872 shares issued and outstanding as of 12/31/14 and 12/31/13, respectively	`CommonStockValue`	$89.76K	USD	Point-in-time
Common Stock, $.001 par value, 200,000,000 shares authorized 89,762,872 and 84,237,872 shares issued and outstanding as of 12/31/14 and 12/31/13, respectively	`CommonStockValue`	$84.24K	USD	Point-in-time
Additional paid in capital	`AdditionalPaidInCapital`	$20.10M	USD	Point-in-time
Additional paid in capital	`AdditionalPaidInCapital`	$34.74M	USD	Point-in-time
Accumulated deficit	`DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage`	$19.92M	USD	Point-in-time
Accumulated deficit	`DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage`	$15.40M	USD	Point-in-time
Total shareholders' equity	`StockholdersEquity`	$2.91M	USD	Point-in-time
Total shareholders' equity	`StockholdersEquity`	$2.01M	USD	Point-in-time
Total shareholders' equity	`StockholdersEquity`	$4.78M	USD	Point-in-time
Total shareholders' equity	`StockholdersEquity`	$14.92M	USD	Point-in-time
TOTAL LIABILITIES & SHAREHOLDERS' EQUITY	`LiabilitiesAndStockholdersEquity`	$15.48M	USD	Point-in-time
TOTAL LIABILITIES & SHAREHOLDERS' EQUITY	`LiabilitiesAndStockholdersEquity`	$5.08M	USD	Point-in-time

Income Statement 99 line items

Line Item	Tag	Value	Unit	Period
Equity compensation	`AllocatedShareBasedCompensationExpense`	$83.14K	USD	Point-in-time
Revenue	`Revenues`	-	USD	1 Quarter
Revenue	`Revenues`	-	USD	Annual
Revenue	`Revenues`	-	USD	1 Quarter
Revenue	`Revenues`	-	USD	Annual
Revenue	`Revenues`	-	USD	1 Quarter
Revenue	`Revenues`	-	USD	Annual
Revenue	`Revenues`	-	USD	1 Quarter
Revenue	`Revenues`	-	USD	1 Quarter
Revenue	`Revenues`	-	USD	1 Quarter
Revenue	`Revenues`	-	USD	1 Quarter
Revenue	`Revenues`	-	USD	1 Quarter
Amortization	`AdjustmentForAmortization`	$160.62K	USD	Annual
Amortization	`AdjustmentForAmortization`	$160.62K	USD	Annual
Amortization	`AdjustmentForAmortization`	$185.27K	USD	Annual
Amortization	`AdjustmentForAmortization`	$160.62K	USD	Point-in-time
Research and development	`ResearchAndDevelopmentExpense`	$1.63M	USD	Annual
Technology Impairment Charge	`OtherAssetImpairmentCharges`	-	USD	Annual
Technology Impairment Charge	`OtherAssetImpairmentCharges`	$345.00K	USD	Annual
Technology Impairment Charge	`OtherAssetImpairmentCharges`	-	USD	Annual
Research and development	`ResearchAndDevelopmentExpense`	$1.63M	USD	Point-in-time
Research and development	`ResearchAndDevelopmentExpense`	$1.13M	USD	Annual
Research and development	`ResearchAndDevelopmentExpense`	$1.52M	USD	Annual
General and administrative	`GeneralAndAdministrativeExpense`	$1.63M	USD	Annual
General and administrative	`GeneralAndAdministrativeExpense`	$2.72M	USD	Annual
Depreciation	`Depreciation`	$10.28K	USD	Annual
General and administrative	`GeneralAndAdministrativeExpense`	$986.10K	USD	Annual
Depreciation	`Depreciation`	-	USD	Annual
Depreciation	`Depreciation`	-	USD	Annual
Total operating expense	`OperatingExpenses`	$1.15M	USD	1 Quarter
Total operating expense	`OperatingExpenses`	$655.91K	USD	1 Quarter
Total operating expense	`OperatingExpenses`	$428.65K	USD	1 Quarter
Total operating expense	`OperatingExpenses`	$1.27M	USD	1 Quarter
Total operating expense	`OperatingExpenses`	$3.27M	USD	Annual
Total operating expense	`OperatingExpenses`	$1.39M	USD	1 Quarter
Total operating expense	`OperatingExpenses`	$790.96K	USD	1 Quarter
Total operating expense	`OperatingExpenses`	$510.21K	USD	1 Quarter
Total operating expense	`OperatingExpenses`	$4.54M	USD	Annual
Total operating expense	`OperatingExpenses`	$1.60M	USD	1 Quarter
Total operating expense	`OperatingExpenses`	$2.58M	USD	Annual
Net operating loss	`OperatingIncomeLoss`	$-1.39M	USD	1 Quarter
Net operating loss	`OperatingIncomeLoss`	$-1.27M	USD	1 Quarter
Net operating loss	`OperatingIncomeLoss`	$-2.58M	USD	Annual
Net operating loss	`OperatingIncomeLoss`	$-510.21K	USD	1 Quarter
Net operating loss	`OperatingIncomeLoss`	$-3.27M	USD	Annual
Net operating loss	`OperatingIncomeLoss`	$-655.91K	USD	1 Quarter
Net operating loss	`OperatingIncomeLoss`	$-1.60M	USD	1 Quarter
Net operating loss	`OperatingIncomeLoss`	$-1.15M	USD	1 Quarter
Net operating loss	`OperatingIncomeLoss`	$-790.96K	USD	1 Quarter
Net operating loss	`OperatingIncomeLoss`	$-4.54M	USD	Annual
Net operating loss	`OperatingIncomeLoss`	$-428.65K	USD	1 Quarter
Interest income	`InvestmentIncomeInterest`	$779.00	USD	Annual
Interest income	`InvestmentIncomeInterest`	$22.63K	USD	Annual
Interest income	`InvestmentIncomeInterest`	$4.04K	USD	Annual
Other expense	`OtherNonoperatingExpense`	$335.00	USD	Annual
Other expense	`OtherNonoperatingExpense`	$637.00	USD	Annual
Other expense	`OtherNonoperatingExpense`	$810.00	USD	Annual
Total Other Income (Expense)	`NonoperatingIncomeExpense`	$22.30K	USD	Annual
Total Other Income (Expense)	`NonoperatingIncomeExpense`	$5.33K	USD	1 Quarter
Total Other Income (Expense)	`NonoperatingIncomeExpense`	$1.40K	USD	1 Quarter
Total Other Income (Expense)	`NonoperatingIncomeExpense`	$1.40K	USD	1 Quarter
Total Other Income (Expense)	`NonoperatingIncomeExpense`	$521.00	USD	1 Quarter
Total Other Income (Expense)	`NonoperatingIncomeExpense`	$3.23K	USD	Annual
Total Other Income (Expense)	`NonoperatingIncomeExpense`	$5.70K	USD	1 Quarter
Total Other Income (Expense)	`NonoperatingIncomeExpense`	$5.24K	USD	1 Quarter
Total Other Income (Expense)	`NonoperatingIncomeExpense`	$6.02K	USD	1 Quarter
Total Other Income (Expense)	`NonoperatingIncomeExpense`	$142.00	USD	Annual
Total Other Income (Expense)	`NonoperatingIncomeExpense`	$-92.00	USD	1 Quarter
Net Loss Before Income Taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-4.52M	USD	Annual
Net Loss Before Income Taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-2.58M	USD	Annual
Net Loss Before Income Taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-3.27M	USD	Annual
Income tax expense	`IncomeTaxExpenseBenefit`	-	USD	Annual
Income tax expense	`IncomeTaxExpenseBenefit`	-	USD	Annual
Income tax expense	`IncomeTaxExpenseBenefit`	-	USD	Annual
Net Loss	`NetIncomeLoss`	$-656.00K	USD	1 Quarter
Net Loss	`NetIncomeLoss`	$-504.88K	USD	1 Quarter
Net Loss	`NetIncomeLoss`	$-789.56K	USD	1 Quarter
Net Loss	`NetIncomeLoss`	$-4.52M	USD	Annual
Net Loss	`NetIncomeLoss`	$-427.24K	USD	1 Quarter
Net Loss	`NetIncomeLoss`	$-1.15M	USD	1 Quarter
Net Loss	`NetIncomeLoss`	$-1.27M	USD	1 Quarter
Net Loss	`NetIncomeLoss`	$-2.58M	USD	Annual
Net Loss	`NetIncomeLoss`	$-1.39M	USD	1 Quarter
Net Loss	`NetIncomeLoss`	$-3.27M	USD	Annual
Net Loss	`NetIncomeLoss`	$-1.60M	USD	1 Quarter
Net loss per share, basic and diluted	`EarningsPerShareBasicAndDiluted`	$-0.01	USD	1 Quarter
Net loss per share, basic and diluted	`EarningsPerShareBasicAndDiluted`	$-0.05	USD	Annual
Net loss per share, basic and diluted	`EarningsPerShareBasicAndDiluted`	$-0.02	USD	1 Quarter
Net loss per share, basic and diluted	`EarningsPerShareBasicAndDiluted`	$-0.01	USD	1 Quarter
Net loss per share, basic and diluted	`EarningsPerShareBasicAndDiluted`	$-0.04	USD	Annual
Net loss per share, basic and diluted	`EarningsPerShareBasicAndDiluted`	$-0.05	USD	Annual
Net loss per share, basic and diluted	`EarningsPerShareBasicAndDiluted`	$-0.01	USD	1 Quarter
Net loss per share, basic and diluted	`EarningsPerShareBasicAndDiluted`	$-0.01	USD	1 Quarter
Net loss per share, basic and diluted	`EarningsPerShareBasicAndDiluted`	$-0.01	USD	1 Quarter
Net loss per share, basic and diluted	`EarningsPerShareBasicAndDiluted`	$-0.02	USD	1 Quarter
Net loss per share, basic and diluted	`EarningsPerShareBasicAndDiluted`	$-0.01	USD	1 Quarter
Basic and diluted weighted average number of common shares outstanding	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	89.28M	shares	Annual
Basic and diluted weighted average number of common shares outstanding	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	71.37M	shares	Annual
Basic and diluted weighted average number of common shares outstanding	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	59.32M	shares	Annual

Cash Flow Statement 80 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-656.00K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-504.88K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-789.56K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-4.52M	USD	Annual
Net loss	`NetIncomeLoss`	$-427.24K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-1.15M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-1.27M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-2.58M	USD	Annual
Net loss	`NetIncomeLoss`	$-1.39M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-3.27M	USD	Annual
Net loss	`NetIncomeLoss`	$-1.60M	USD	1 Quarter
Amortization	`AdjustmentForAmortization`	$160.62K	USD	Annual
Amortization	`AdjustmentForAmortization`	$160.62K	USD	Annual
Amortization	`AdjustmentForAmortization`	$185.27K	USD	Annual
Amortization	`AdjustmentForAmortization`	$160.62K	USD	Point-in-time
Depreciation	`Depreciation`	$10.28K	USD	Annual
Depreciation	`Depreciation`	-	USD	Annual
Depreciation	`Depreciation`	-	USD	Annual
Technology impairment	`OtherAssetImpairmentCharges`	-	USD	Annual
Technology impairment	`OtherAssetImpairmentCharges`	$345.00K	USD	Annual
Technology impairment	`OtherAssetImpairmentCharges`	-	USD	Annual
Common stock issed for services	`IssuanceOfStockAndWarrantsForServicesOrClaims`	-	USD	Annual
Common stock issed for services	`IssuanceOfStockAndWarrantsForServicesOrClaims`	$18.50K	USD	Annual
Common stock issed for services	`IssuanceOfStockAndWarrantsForServicesOrClaims`	-	USD	Annual
Stock options and warrants	`ShareBasedCompensation`	$404.15K	USD	Annual
Stock options and warrants	`ShareBasedCompensation`	$63.38K	USD	Annual
Stock options and warrants	`ShareBasedCompensation`	$704.48K	USD	Annual
Prepaid drug product for testing	`IncreaseDecreaseInInventories`	$-143.64K	USD	Annual
Prepaid drug product for testing	`IncreaseDecreaseInInventories`	$42.00K	USD	Annual
Prepaid drug product for testing	`IncreaseDecreaseInInventories`	$103.30K	USD	Annual
Other current assets	`IncreaseDecreaseInOtherCurrentAssets`	$-5.86K	USD	Annual
Other current assets	`IncreaseDecreaseInOtherCurrentAssets`	$36.38K	USD	Annual
Other current assets	`IncreaseDecreaseInOtherCurrentAssets`	$21.54K	USD	Annual
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$13.11K	USD	Annual
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$267.07K	USD	Annual
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-34.35K	USD	Annual
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$-1.99M	USD	Annual
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$-3.82M	USD	Annual
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$-2.31M	USD	Annual
Purchase of exclusive license - related party	`PaymentsToAcquireIntangibleAssets`	$25.00K	USD	Annual
Purchase of exclusive license - related party	`PaymentsToAcquireIntangibleAssets`	-	USD	Annual
Purchase of exclusive license - related party	`PaymentsToAcquireIntangibleAssets`	-	USD	Annual
Purchase furniture, fixtures & equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	-	USD	Annual
Purchase furniture, fixtures & equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	-	USD	Annual
Purchase furniture, fixtures & equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$123.41K	USD	Annual
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivitiesContinuingOperations`	$-25.00K	USD	Annual
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivitiesContinuingOperations`	$-123.41K	USD	Annual
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivitiesContinuingOperations`	-	USD	Annual
Net proceeds from sale of common stock	`ProceedsFromIssuanceOfCommonStock`	$13.81M	USD	Annual
Net proceeds from sale of common stock	`ProceedsFromIssuanceOfCommonStock`	$5.33M	USD	Annual
Net proceeds from sale of common stock	`ProceedsFromIssuanceOfCommonStock`	$1.60M	USD	Annual
Net proceeds from exercise of common stock options	`ProceedsFromStockOptionsExercised`	$435.50K	USD	Annual
Net proceeds from exercise of common stock options	`ProceedsFromStockOptionsExercised`	-	USD	Annual
Net proceeds from exercise of common stock options	`ProceedsFromStockOptionsExercised`	-	USD	Annual
Net cash from financing activities	`NetCashProvidedByUsedInFinancingActivitiesContinuingOperations`	$14.25M	USD	Annual
Net cash from financing activities	`NetCashProvidedByUsedInFinancingActivitiesContinuingOperations`	$5.33M	USD	Annual
Net cash from financing activities	`NetCashProvidedByUsedInFinancingActivitiesContinuingOperations`	$1.60M	USD	Annual
NET INCREASE (DECREASE) IN CASH	`CashPeriodIncreaseDecrease`	$3.02M	USD	Annual
NET INCREASE (DECREASE) IN CASH	`CashPeriodIncreaseDecrease`	$-418.21K	USD	Annual
NET INCREASE (DECREASE) IN CASH	`CashPeriodIncreaseDecrease`	$10.31M	USD	Annual
Cash, beginning of period	`Cash`	$13.86M	USD	Point-in-time
Cash, beginning of period	`Cash`	$3.55M	USD	Point-in-time
Cash, beginning of period	`Cash`	$952.25K	USD	Point-in-time
Cash, beginning of period	`Cash`	$534.05K	USD	Point-in-time
Cash, end of period	`Cash`	$13.86M	USD	Point-in-time
Cash, end of period	`Cash`	$3.55M	USD	Point-in-time
Cash, end of period	`Cash`	$952.25K	USD	Point-in-time
Cash, end of period	`Cash`	$534.05K	USD	Point-in-time
Interest	`InterestPaid`	-	USD	Annual
Interest	`InterestPaid`	-	USD	Annual
Interest	`InterestPaid`	-	USD	Annual
Income taxes	`IncomeTaxesPaid`	-	USD	Annual
Income taxes	`IncomeTaxesPaid`	-	USD	Annual
Income taxes	`IncomeTaxesPaid`	-	USD	Annual
Common stock issued to Placement Agent	`StockIssued1`	$771.05K	USD	Annual
Common stock issued to Placement Agent	`StockIssued1`	-	USD	Annual
Common stock issued to Placement Agent	`StockIssued1`	-	USD	Annual
Due diligence and commitment shares issued	`ConversionOfStockAmountIssued1`	-	USD	Annual
Due diligence and commitment shares issued	`ConversionOfStockAmountIssued1`	$1.75K	USD	Annual
Due diligence and commitment shares issued	`ConversionOfStockAmountIssued1`	-	USD	Annual

Stockholders Equity 29 line items

Line Item	Tag	Value	Unit	Period
Beginning balance	`StockholdersEquity`	$2.91M	USD	Point-in-time
Beginning balance	`StockholdersEquity`	$2.01M	USD	Point-in-time
Beginning balance	`StockholdersEquity`	$4.78M	USD	Point-in-time
Beginning balance	`StockholdersEquity`	$14.92M	USD	Point-in-time
Common stock issued	`StockIssuedDuringPeriodValueNewIssues`	$15.00M	USD	Point-in-time
Stock option vesting	`AdjustmentsToAdditionalPaidInCapitalOther`	$63.38K	USD	Annual
Stock option vesting	`AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition`	$404.15K	USD	Annual
Stock option vesting	`AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition`	$704.48K	USD	Annual
Fund raising expense	`AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts`	$304.16K	USD	Annual
Fund raising expense	`AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts`	$1.19M	USD	Annual
Fund raising expense	`AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts`	$1.40M	USD	Annual
Shares issued for common stock previously sold	`StockIssuedDuringPeriodValuePreviouslySold`	-	USD	Annual
Net loss	`NetIncomeLoss`	$-656.00K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-504.88K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-789.56K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-4.52M	USD	Annual
Net loss	`NetIncomeLoss`	$-427.24K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-1.15M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-1.27M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-2.58M	USD	Annual
Net loss	`NetIncomeLoss`	$-1.39M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-3.27M	USD	Annual
Net loss	`NetIncomeLoss`	$-1.60M	USD	1 Quarter
Ending balance	`StockholdersEquity`	$2.91M	USD	Point-in-time
Ending balance	`StockholdersEquity`	$2.01M	USD	Point-in-time
Ending balance	`StockholdersEquity`	$4.78M	USD	Point-in-time
Ending balance	`StockholdersEquity`	$14.92M	USD	Point-in-time
Exercise of stock options (in shares)	`StockIssuedDuringPeriodSharesStockOptionsExercised`	525,000.00	shares	Annual
Exercise of stock options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$435.50K	USD	Annual

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.